The Fly has brought its right-to-the-point stock market reporting to YouTube! Subscribe if you want to know how the markets will open and what stocks traders will be focused on.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SRPT:
- Sarepta downgraded to Sell from Neutral at H.C. Wainwright
- Sarepta Therapeutics Maintains Buy Rating Amid Proactive Safety Measures for Elevidys Treatment
- Sarepta downgraded to Neutral from Overweight at Piper Sandler
- Sarepta Therapeutics: Buy Rating Affirmed Amid Strategic Safety Measures and Long-Term Potential
- Sarepta Therapeutics: Hold Rating Amid Elevidys Safety Concerns and Revised Sales Forecast